Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

930.67
USD
-42.69
(-4.39%)
45.15EPS
16.19P/E
78.42BMarket Cap
Jan 29Next Earn

Regeneron Pharmaceuticals, Inc. Documents

Q1 FY2026 · Presentation

REGN Roundtable C5 Presentation FINAL · 40 pages

Read Regeneron Pharmaceuticals, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents